[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2013-02-28

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The first phase of the study will investigate if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

FLT-PET Imaging of Brain Tumors in Children

NCT01244737

Brain Neoplasms

COMPLETED PHASE2

A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors

NCT00633958

Tumors of the Central Nervous System

TERMINATED PHASE1

PET Imaging of Intracranial Cancers With 18F-FSPG

NCT02370563

Brain Cancer

TERMINATED PHASE1

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

NCT03541720

Neuroblastoma Pheochromocytoma

ACTIVE_NOT_RECRUITING EARLY_PHASE1

18F-DOPA II - PET Imaging Optimization

NCT04706910

Congenital Hyperinsulinism Neuroblastoma Parkinson Disease +3 more

RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The first phase of the study will investigate if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue. Tne subjects between ages 5 and 17 years will be studies, to determine if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue. Drug safety will also be monitored.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phase I

Children, ages 5-15 years with brain tumors

[F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical

Intervention Type DRUG

A single dosage of the diagnostic drug will be administered to individuals who meet inclusion criteria after informed consent.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

[F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical

A single dosage of the diagnostic drug will be administered to individuals who meet inclusion criteria after informed consent.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented brain tumor at diagnosis or relapse, including high grade glioma, low grade glioma, medulloblastoma including PNET, optic pathway glioma, brainstem glioma, ependymoma.